Inavein

Lexington, United States Founded: 2007 • Age: 19 yrs Acquired By LeMaitre Vascular
Varicose and spider vein treatment devices are developed and marketed.

About Inavein

Inavein is a Healthcare company based in Lexington (United States) founded in 2007, and was acquired by LeMaitre Vascular in August 2013. Varicose and spider vein treatment devices are developed and marketed. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Inavein LLC. Its competitors include Tactile Medical, enVVeno Medical and Veniti; 2 of its 3 listed competitors have raised funding.

Company details

Inavein was founded in 2007 in Lexington, United States, within the medical devices sector focused on vein abnormalities. Devices for varicose and spider vein removal are developed, manufactured, and marketed, including the TRIVEX System for transilluminated phlebectomy, the TCI System for saphenous vein removal, and the Tumescent Enhanced Sclerotherapy System for spider vein treatment. The company was acquired by LeMaitre Vascular in 2013 for 2.5 million.

  • Headquarters Lexington, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website inavein.com
  • Acquired by LeMaitre Vascular (Aug 2013)
  • Legal Name Inavein Llc
Key Metrics

Investors in Inavein

Inavein has secured backing from 1 investor. Prominent investors backing the company include LeMaitre Vascular.

All
InvestorDescriptionFounded YearDomainLocation
Devices for peripheral vascular disease treatment are developed and marketed.
1983lemaitre.comBurlington, United States
Premium access

Investor details for Inavein

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Inavein

2 dated milestones of Inavein across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Inavein is founded.
  2. Exit Acquired by LeMaitre Vascular.

Competitors of Inavein

Inavein has 3 listed competitors in our database, 2 of them funded. They include Tactile Medical, enVVeno Medical and Veniti.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tactilemedical.com1995Minneapolis, United States$23.2M592
Home therapy devices for lymphedema and venous ulcers are provided.
envveno.com1999Irvine, United States31
Developer of medical device for the the treatment of venous diseases
veniti.com2010St. Louis, United States$65.22M
A self-expanding stent system for chronic venous disease is developed.
Premium access

Detailed competitors of Inavein

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Inavein (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Inavein

Inavein was founded in 2007.

Inavein is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Inavein was founded in 2007 in Lexington, United States, within the medical devices sector focused on vein abnormalities. Devices for varicose and spider vein removal are developed, manufactured, and marketed, including the TRIVEX System for transilluminated phlebectomy, the TCI System for saphenous vein removal, and the Tumescent Enhanced Sclerotherapy System for spider vein treatment. The company was acquired by LeMaitre Vascular in 2013 for 2.5 million.

Inavein's top competitors include Tactile Medical, enVVeno Medical and Veniti.

Inavein has 1 investor. Key investors include LeMaitre Vascular.

Inavein operates through Inavein Llc.

Yes. Inavein was acquired by LeMaitre Vascular in August 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available